The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Piroxicam Therapy in 34 Dogs With Transitional Cell Carcinoma of the Urinary Bladder
Open accessAbstract
Abstarct: Thirty-four dogs with histopathologically confirmed, measurable, nonresectable transitional cell carcinoma of the urinary bladder were treated with piroxicam (0.3 mg/kg PO sid) and were evaluated for tumor response and drug toxicity. Dogs were evaluated at the Purdue University Veterinary Teaching Hospital by means of physical examination, thoracic and abdominal radiography, cystography, complete blood count, serum biochemistry profile, and urinalysis. In selected cases, prostaglandin E2 (PGE2) concentrations in plasma and in supernatants of stimulated monocytes, and natural killer cell activity were quantified, Dogs were evaluated before therapy and at 28 and 56 days after initiation of therapy. Dogs with stable disease or remission at 56 days remained on the study and were evaluated at 1 to 2 month intervals. Tumor responses were 2 complete remissions, 4 partial remissions, 18 stable diseases. and 10 progressive diseases. The median survival of all dogs was 181 days (range, 28 to 720+ days), with 2 dogs still alive. Piroxicam toxicity consisted of gastrointestinal irritation in 6 dogs and renal papillary necrosis (detected at necropsy) in 2 dogs. Monocyte production of PGE2 appeared to decrease with therapy in dogs whose tumors were decreasing in size, and increased in dogs with tumor progression. A consistent pattern in natural killer cell activity was not observed. In vitro cytotoxicity assays against 4 canine tumor cell lines revealed no direct antitumor effects of piroxicam. In summary, antitumor activity, which was not likely the result of a direct cytotoxic effect, was observed in dogs with transitional cell carcinoma of the bladder treated with piroxicam.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods in Medical Research.
Armitage, P. (1972) · Biometrics · doi:10.2307/2556182 · Cited by 4,029
Prostaglandins as Mediators of Hypercalcemia Associated with Certain Types of Cancer
Seyberth, H. W., Segre, G. V., Morgan, J. L., Sweetman, B. J., Potts, J. T., & Oates, J. A. (1975) · New England Journal of Medicine · doi:10.1056/nejm197512182932502 · Cited by 459
Prostaglandin E inhibits the production of human interleukin 2.
Rappaport, R. S., & Dodge, G. R. (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.3.943 · Cited by 421
Inhibition of murine natural killer cell activity by prostaglandins.
Brunda, M. J., Herberman, R. B., & Holden, H. T. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.124.6.2682 · Cited by 417
Reddy, B. S., Maruyama, H., & Kelloff, G. V. (1987) · PubMed · Cited by 302
Phase I trial of piroxicam in 62 dogs bearing naturally occurring tumors
Knapp, D. W., Richardson, R. C., Bottoms, G. D., Teclaw, R. F., & Chan, T. (1992) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00686255 · Cited by 125
Self-citationNigro, N. D., Bull, A. W., & Boyd, M. E. (1986) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/77.6.1309 · Cited by 111
The suppressive effect of piroxicam on autochthonous intestinal tumors in the rat
Pollard, M., Luckert, P. H., & Schmidt, M. A. (1983) · Cancer Letters · doi:10.1016/0304-3835(83)90082-4 · Cited by 106
Effect of piroxicam on primary intestinal tumors induced in rats by N-methylnitrosourea
Pollard, M., & Luckert, P. H. (1984) · Cancer Letters · doi:10.1016/s0304-3835(84)80035-x · Cited by 86
Changes in the host natural killer cell population in mice during tumor development
Parhar, R. S., & Lala, P. K. (1985) · Cellular Immunology · doi:10.1016/0008-8749(85)90133-9 · Cited by 81
Cited by
Urinary Bladder Cancer in Dogs, a Naturally Occurring Model for Cancer Biology and Drug Development
Knapp, D. W., Ramos-Vara, J. A., Moore, G. E., Dhawan, D., Bonney, P. L., & Young, K. E. (2014) · ILAR Journal · doi:10.1093/ilar/ilu018 · Cited by 284
Self-citationCanine Transitional Cell Carcinoma
Mutsaers, A. J., Widmer, W. R., & Knapp, D. W. (2003) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2003.tb02424.x · Cited by 281
Self-citationAnimal models and therapeutic molecular targets of cancer: utility and limitations
Cekanova, M., & Rathore, K. (2014) · Drug Design, Development and Therapy · doi:10.2147/dddt.s49584 · Cited by 274
Gardner, H. L., Fenger, J. M., & London, C. A. (2016) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-022114-110911 · Cited by 215
Metadata
- Authors
- Knapp, D. W., Richardson, R. C., Chan, T. C. K., Bottoms, G. D., Widmer, W. R., DeNicola, D. B., Teclaw, R., Bonney, P. L., & Kuczek, T.
- Venue
- Journal of Veterinary Internal Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 1994-07-01
- Volume
- 8
- Issue
- 4
- Pages
- 273-278
- ISSN
- 0891-6640 (ISSN-L)
- 1939-1676
- OpenAlex
- W1986616957
- Cited by
- 303
- References
- 12
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Piroxicam Therapy in 34 Dogs With Transitional Cell Carcinoma of the Urinary Bladder. https://app.cochat.ai/papers/10.1111/j.1939-1676.1994.tb03232.x
- The paper
- Knapp, D. W., Richardson, R. C., Chan, T. C. K., Bottoms, G. D., Widmer, W. R., DeNicola, D. B., Teclaw, R., Bonney, P. L., & Kuczek, T. (1994). Piroxicam Therapy in 34 Dogs With Transitional Cell Carcinoma of the Urinary Bladder. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/j.1939-1676.1994.tb03232.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.